Orthopedic device manufacturer Implanet reported more than $3.3 million in revenue during the third quarter of 2025, according to an Oct. 7 news release from the company.
Here are five financial notes to know:
- The company’s 2025 third quarter revenue represents a 26% increase from the third quarter in 2024.
- Implanet has a nine-month 2025 revenue of more than $10 million, an increase of 36% compared to the same period last year.
- U.S. activity grew 22% in the third quarter of 2025 compared to 2024.
- Implanet’s U.S. revenue surpassed $1 million in the third quarter of 2025, driven by the initial roll out of the company’s Jazz Spinal System.
- Revenue from spine implants increased 33% in 2025’s third quarter compared to 2024, and medical equipment revenue climbed 13% over the same period.
